23 Feb Aspen Neuroscience
Posted at 18:43h
in
Kim Raineri, Chief Technology Officer
Oct. 5 | 11:00am | FLW Ballroom F
San Diego, CA
(Private)
Aspen Neuroscience is a leading, clinical-stage regenerative medicine biotechnology company developing autologous induced pluripotent stem cell-derived (iPSC) therapies beginning with neurodegenerative diseases of high unmet need including Parkinson’s disease (PD). Its lead product candidate is sasineprocel (ANPD-001), the most advanced autologous investigational cell therapy in the United States for treating PD.